Home
English
English
简体中文
Sign In
BPG Management System
F6Publishing-Submit a Manuscript
F6Publishing-世界华人消化杂志在线投稿
RCA Management System
Help Desk
Journals
Login
Advanced Search
BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Featured Articles
Journals
Submit a Manuscript
Home
Archive
Volume 31, Issue 48
Cited by in CrossRef
For:
Zhang X, Liao MJ, Ren LY, Qin WY, Mu SW, She SP, Fei R, Cong X, Zhou YP, Chen DB, Chen HS. AADN score: Predicting response to transarterial chemoembolization, sintilimab and lenvatinib in patients with hepatocellular carcinoma.
World J Gastroenterol
2025; 31(48): 113856 [PMID:
41480328
DOI:
10.3748/wjg.v31.i48.113856
]
URL:
https://www.wjgnet.com/1007-9327/full/v31/i48/113856.htm
(
37
)
(
61
)
(
0
)
(
0
)
(
0
)
(
9
)
(
1
)
(
790
)
(
1
)
Number
Citing Articles
1
Cristian Lindner.
Letter to the Editor: AADN score predicts overall and progression-free survival in triple therapy for hepatocellular carcinoma
.
World Journal of Gastroenterology
2026;
32(13)
: 116481
doi:
10.3748/wjg.v32.i13.116481
Abstract(69)
|
Core Tip(80)
|
Full Article(HTML)(229)
|
Full Article (PDF)-334K(38)
|
Full Article with Cover (PDF)-1049K(96)
|
Full Article (XML)-38K(22)
|
Audio-214K(4)
|
Peer-Review Report-190K(24)
|
Answering Reviewers-109K(27)
|
Times Cited (0)
|
Total Visits (385)
|
Open
Core Tip
All content on this site:
Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
Loading
Login